People with chronic bad backs may soon have cause to jump for joy—carefully, of course. A large-scale, randomized, double-blinded, and controlled clinical trial has shown that a specifically formulated cannabis extract can significantly alleviate people’s back pain.

German-based pharmaceutical company Vertanical developed the extract, code-named VER-01, and sponsored the phase III trial. People who took VER-01 experienced a greater reduction in pain compared to people on a placebo, the study researchers found. The company has already filed for regulatory approval of its drug in Europe and is planning to secure approval from the U.S. Food and Drug Administration as well.

Robust evidence

The trial, conducted in several different phases, involved over 800 adults diagnosed with chronic lo

See Full Page